Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Exploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
The Role of B-Cell Depletion in MS Care
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Recurrence as the Rule: BD Symptoms Persist and Cycle
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Uncovering TK2d: How to Navigate Diagnostic Challenges
Navigating Emerging Biomarkers in MS Care
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Immunologic Phenotyping: The Future of Personalized MG Care
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Precision Medicine for Myasthenia Gravis
Discharge Planning After Myasthenic Crisis
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.